A pilot study involving administration of combination anti-retroviral therapy [antiretrovirals] and transplantation of HLA [human leukocyte antigen]-matched sibling peripheral blood stem cells or partially HLA-matched unrelated umbilical cord blood in adults with HIV infection and hematologic malignancies.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Antiretrovirals; Antithymocyte globulin; Melphalan
- Indications HIV infections
- Focus Adverse reactions; Therapeutic Use
- 07 Mar 2013 Biomarkers information updated
- 06 Mar 2013 Status changed from active, no longer recruiting to withdrawn prior to recruitment as reported by ClinicalTrials.gov.
- 13 Dec 2011 Additional lead trial centre identified as reported by ClinicalTrials.gov.